Sartorius AG (SRT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sartorius AG (SRT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7189
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for efficient biologic manufacture of medications and vaccines. Sartorius also offers wide range of products for purification, separation and concentration, and solutions for storage and transportation of intermediate and final biological products. The company serves pharmaceutical, biotechnology, chemical, food and beverage industries, and numerous research and educational institutes and laboratories in Germany and across the world. It has manufacturing facilities in Europe, Asia and America. Sartorius is headquartered in Goettingen, Niedersachsen, Germany.

Sartorius AG (SRT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sartorius AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sartorius AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sartorius AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sartorius AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sartorius AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sartorius AG, Medical Equipment, Deal Details 10
Venture Financing 10
IntelliCyt Raises USD5.4 Million in Venture Financing Round 10
IntelliCyt Raises USD0.05 Million in Venture Financing 11
IntelliCyt Raises US$8.4 Million In Series B Financing 12
ViroCyt Raises Funds In Second Round Of Growth Financing 13
Partnerships 14
Sartorius Stedim Biotech Enters into Agreement with Nova Biomedical 14
Notable Labs Enters into Agreement with IntelliCyt 15
Genedata Enters into Integration Agreement with IntelliCyt 16
Sartorius Stedim Biotech Enters Into An Agreement With Bosch Packaging 17
Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 18
Acquisition 19
Sartorius Acquires Essen BioScience for USD320 Million 19
Sartorius Stedim Biotech Acquires kSep for USD32.6 Million 20
Sartorius Acquires ViroCyt for USD18.5 Million 21
Sartorius Acquires IntelliCyt for USD103.8 Million 22
Sartorius AG – Key Competitors 23
Sartorius AG – Key Employees 24
Sartorius AG – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 28
Financial Announcements 28
Jul 24, 2018: Business Figures for the First Half of 2018: Sartorius Records Double-Digit Sales Growth 28
Jan 31, 2018: Sartorius grows significantly again in sales revenue and earnings in 2017 – positive outlook for 2018 30
Jul 21, 2017: Business Figures for the First Half of 2017: Sartorius Continues to Grow 32
Jul 21, 2017: Solid growth at Sartorius Stedim Biotech; profits continue to rise 34
Apr 24, 2017: First-quarter figures: Sartorius starts off 2017 with double-digit growth 35
Feb 23, 2017: Sartorius Reviews Fiscal 2016 36
Jan 30, 2017: Sartorius Grows by Double Digits in Sales Revenue and Earnings in 2016 – Positive Outlook for 2017 38
Corporate Communications 40
Mar 09, 2017: Sartorius appoints Gerry MacKay as Executive Vice President of Marketing, Sales and Services for its Laboratory Division 40
Feb 21, 2017: Resolutions of the Sartorius Supervisory Board 41
Other Significant Developments 42
Oct 16, 2017: Sartorius Group: Key Figures on 9-Month Business Development in 2017 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Sartorius AG, Medical Equipment, Key Facts, 2017 2
Sartorius AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sartorius AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sartorius AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sartorius AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sartorius AG, Deals By Market, 2012 to YTD 2018 8
Sartorius AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
IntelliCyt Raises USD5.4 Million in Venture Financing Round 10
IntelliCyt Raises USD0.05 Million in Venture Financing 11
IntelliCyt Raises US$8.4 Million In Series B Financing 12
ViroCyt Raises Funds In Second Round Of Growth Financing 13
Sartorius Stedim Biotech Enters into Agreement with Nova Biomedical 14
Notable Labs Enters into Agreement with IntelliCyt 15
Genedata Enters into Integration Agreement with IntelliCyt 16
Sartorius Stedim Biotech Enters Into An Agreement With Bosch Packaging 17
Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 18
Sartorius Acquires Essen BioScience for USD320 Million 19
Sartorius Stedim Biotech Acquires kSep for USD32.6 Million 20
Sartorius Acquires ViroCyt for USD18.5 Million 21
Sartorius Acquires IntelliCyt for USD103.8 Million 22
Sartorius AG, Key Competitors 23
Sartorius AG, Key Employees 24
Sartorius AG, Other Locations 25
Sartorius AG, Subsidiaries 25

List of Figures
Sartorius AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sartorius AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sartorius AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sartorius AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sartorius AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sartorius AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sartorius AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sartorius AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sartorius AG (SRT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RISE Life Science Corp:企業のM&A・事業提携・投資動向
    RISE Life Science Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RISE Life Science Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Egalet Corp (EGLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Egalet Corp (Egalet) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for pain and other conditions. Its product portfolio includes OXAYDO (oxycodone HCl, USP) tablets CII for the management of acute and chronic moderate to severe pain; SP …
  • Bulgarian Telecommunications Company (VIVACOM):企業の戦略的SWOT分析
    Bulgarian Telecommunications Company (VIVACOM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Hosken Consolidated Investments Ltd (HCI):企業の財務・戦略的SWOT分析
    Hosken Consolidated Investments Ltd (HCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • BioLineRx Ltd (BLRX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioLineRx Ltd (BioLineRx) is a clinical stage biopharmaceutical company that focuses on the identification, in-licensing, and development of products to address unmet medical needs. The company focuses mainly on cancer and immunology. Its’s product pipeline includes BL-8040, a short peptide …
  • Consejo Superior de Investigaciones Cientificas-製薬・医療分野:企業M&A・提携分析
    Summary Consejo Superior de Investigaciones Cientificas (CSIC) is a research institute that provides research capacity, and human and material resources to conduct research projects. The institute offers multidisciplinary scientific and technical research, scientific and technical advice, management …
  • Bavarian Nordic AS (BAVA):企業の財務・戦略的SWOT分析
    Bavarian Nordic AS (BAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Healthscope Ltd (HSO):製薬・医療:M&Aディール及び事業提携情報
    Summary Healthscope Ltd (Healthscope) is an integrated healthcare provider that provides healthcare services through the ownership and management of hospitals and pathology laboratories. The company operates through private hospitals in Australia and pathology laboratories in New Zealand. It provide …
  • Enercon Services Inc:電力:M&Aディール及び事業提携情報
    Summary Enercon Services, Inc. (Enercon) is a diversified consulting company offering architectural engineering, environmental, technical and management services. Its offerings include licensing, operations, permitting, construction, decommissioning, and staff augmentation, cyber security and regula …
  • Orsted AS (ORSTED):企業の財務・戦略的SWOT分析
    Orsted AS (ORSTED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • AGL Energy Ltd (AGL)-石油・ガス分野:企業M&A・提携分析
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Painted Pony Energy Ltd (PONY):石油・ガス:M&Aディール及び事業提携情報
    Summary Painted Pony Energy Ltd (Painted Pony Energy), formerly Painted Pony Petroleum Ltd is a natural gas producer that offers production development drilling for natural gas and natural gas liquids. The company offers development of its premium, sweet natural gas resource base located in the opti …
  • Rigel Pharmaceuticals Inc (RIGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease me …
  • Albéa Beauty Holdings S.A.:戦略・SWOT・企業財務分析
    Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report Summary Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Hexcel Corp (HXL):企業の財務・戦略的SWOT分析
    Hexcel Corp (HXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Roadrunner Transportation Systems Inc.:企業のM&A・事業提携・投資動向
    Roadrunner Transportation Systems Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Roadrunner Transportation Systems Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • BBVA Banco Frances S.A. (FRAN3):企業の財務・戦略的SWOT分析
    BBVA Banco Frances S.A. (FRAN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Enyo Pharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Enyo Pharma SA (Enyo Pharma) is a biopharmaceutical company that develops molecules modulating host functions for the treatment of acute and chronic viral infections. The company provides technology which develops tools combining biological experimentation and computational development to id …
  • Avara Pharmaceutical Services Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avara Pharmaceutical Services Inc (Avara) is a contract development and manufacturing organization that provides primary formulation and manufacturing, secondary manufacturing and packaging of small molecules. It offers wide range of services such as manufacturing of active pharmaceutical in …
  • Akebia Therapeutics Inc (AKBA):企業の財務・戦略的SWOT分析
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆